1174289-21-4

Basic information

• Product Name: (R )-1-Amino-3-methoxy-propan-2-ol
• Synonyms: (R)-1-Amino-3-methoxy-2-propanol;(2R)-1-amino-3-methoxypropan-2-ol;(R )-1-Amino-3-methoxy-propan-2-ol
• CAS NO: 1174289-21-4
• Molecular Formula: C₄H₁₁NO₂
• Molecular Weight: 105.14
• Product Categories: pharmacetical
• Mol File: 1174289-21-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R )-1-Amino-3-methoxy-propan-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (R )-1-Amino-3-methoxy-propan-2-ol(1174289-21-4)
• EPA Substance Registry System: (R )-1-Amino-3-methoxy-propan-2-ol(1174289-21-4)

Safety Data

• Hazardous Substances Data: 1174289-21-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(R)-1-amino-3-methoxypropan-2-ol is used as a chiral building block for the synthesis of enantiopure bioactive compounds. Its stereochemistry plays a crucial role in the development of pharmaceuticals with desired therapeutic effects and minimal side effects.
Used in Agrochemical Industry:
(R)-1-amino-3-methoxypropan-2-ol is used as a chiral auxiliary in the production of crop protection agents. Its enantiopure form ensures the creation of agrochemicals with targeted effects on pests, reducing the risk of non-specific environmental impact.
Used in Organic Synthesis:
(R)-1-amino-3-methoxypropan-2-ol is used as a chiral auxiliary for the formation of chiral amines and amino alcohols. Its unique stereochemistry allows for the creation of complex organic molecules with specific properties and functions.
Used in Catalytic Asymmetric Synthesis:
(R)-1-amino-3-methoxypropan-2-ol is used as a ligand in catalytic asymmetric synthesis, enabling the production of enantiomerically pure compounds with high selectivity and efficiency. This application is vital for the development of advanced materials and pharmaceuticals with improved performance and reduced environmental impact.

Upstream product

• 64491-70-9 R(-)-glycidyl methyl ether 
• 922522-04-1 C₄H₉N₃O₂ 

Downstream Products

• 922522-05-2 (R)-3-methoxy-1-(4-monomethoxytrityl)aminopropan-2-ol 

Relevant articles and documents

1-HETEROARYL-INDOLINE-4-CARBOXAMIDES AS MODULATORS OF GPR52 USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO

The present invention relates to compounds of Formula (la) and pharmaceutical compositions thereof that modulate the activity of GPR52. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a GPR52-mediated disorder (e.g., Huntington's disease, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder (ADHD), or Tourette's syndrome); an extrapyramidal or movement disorder; a motor disorder; a hyperkinetic movement disorder; a psychotic disorder; catatonia; a mood disorder; a depressive disorder; an anxiety disorder; obsessive-compulsive disorder (OCD); an autism spectrum disorder; a prolactin-related disorder (e.g., hyperprolactinemia); a neurocognitive disorder; a trauma- or stressor-related disorder (e.g., posttraumatic stress disorder (PTSD)); a disruptive, impulse-control, or conduct disorder; a sleep-wake disorder; a substance-related disorder; an addictive disorder; a behavioral disorder; hypofrontality; an abnormality in the tuberoinfundibular, mesolimbic, mesocortical, or nigrostriatal pathway; decreased activity in the striatum; cortical dysfunction; neurocognitive dysfunction; and conditions related thereto.

SUBSTITUTED PYRIDINES AND METHOD OF USE

The invention discloses compounds of Formula (I) wherein X, R1, R2, and R3 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

Novel amino linkers enabling efficient labeling and convenient purification of amino-modified oligonucleotides

We developed new amino linker reagents for an oligonucleotide (ONT) terminus. These reagents consist of an aminoethyl carbamate main linkage and a side-chain residue, which was a naphthylmethoxymethyl, methoxymethyl, or methyl group or a hydrogen atom. Th